Kazuyasu Miyoshi

1.7k citations
16 papers · 927 indexed · 1 hit paper · h-index 7
Topics
SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 detection and testing (4 papers)
Partner nations
Japan

In The Last Decade

Kazuyasu Miyoshi

15 papers receiving 915 citations

Hit Papers

SARS-CoV-2 D614G spike mutation increases entry efficienc...20212026202220242021100200300

Peers

Kazuyasu Miyoshi
Comparison fields: 5 of 92
  • Infectious Diseases 783
  • Molecular Biology 208
  • Biomedical Engineering 186
  • Radiology, Nuclear Medicine and Imaging 129
  • Neurology 111
Replace Owen Tak‐Yin Tsang with:
Owen Tak‐Yin Tsang Hong Kong
Anthony Chin‐Ki Ng Hong Kong
Zijiao Zou China
Sebastian Hoehl Germany
Kit‐Hang Leung China
Xiao-Shuang Zheng China
Tommy Hing‐Cheung Tang China
Allen Wing‐Ho Chu Hong Kong
Heui Man Kim South Korea
Kazuyasu Miyoshi relative to Owen Tak‐Yin Tsang Hong Kong Owen Tak‐Yin Tsang's profile →
Citations per field
00.5×1.6×
Owen Tak‐Yin Tsang · 1×
Citations per year

Countries citing papers authored by Kazuyasu Miyoshi

Since Specialization
Citations

This map shows the geographic impact of Kazuyasu Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuyasu Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuyasu Miyoshi more than expected).

Fields of papers citing papers by Kazuyasu Miyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuyasu Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuyasu Miyoshi. The network helps show where Kazuyasu Miyoshi may publish in the future.

Co-authorship network of co-authors of Kazuyasu Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuyasu Miyoshi. A scholar is included among the top collaborators of Kazuyasu Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuyasu Miyoshi. Kazuyasu Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 4
2
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinitybreakdown →
310
3 41
4 11
5 82
6 170
7 11
8 283
9 2
10 0
11 4
12 4
13 1
14 2
15
[Reproduction study on netilmicin. (1) Teratological study in rats (author's transl)].
1
16
[Cefazolin. 2. Primary clinical trial by oral administration].
1

About Kazuyasu Miyoshi

Kazuyasu Miyoshi is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 16 papers that have together received 927 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). The work is most often cited by research in Infectious Diseases (783 citations), General Dentistry (38 citations) and Modeling and Simulation (63 citations). Kazuyasu Miyoshi has collaborated with scholars based in Japan. Frequent co-authors include Kazuo Imai, Toshimitsu Ito, Kaku Tamura, Sakiko Tabata, Satoshi Mimura, Takamasa Ueno, Yasumasa Iwatani, Toong Seng Tan, Satoshi Kishigami and Hirotaka Ode. Their work appears in journals such as Nature Communications, Journal of Clinical Microbiology and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026